Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
290.28
+1.28 (0.44%)
Nov 10, 2026, 4:00 PM EST - Market closed
Tenet Healthcare Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 23,103 | 17,465 | 12,004 | 7,674 | 5,275 | 8,751 | |
Market Cap Growth | 26.01% | 45.49% | 56.42% | 45.48% | -39.72% | 107.70% |
Enterprise Value | 33,672 | 32,363 | 25,022 | 25,379 | 22,500 | 23,554 |
Last Close Price | 289.00 | 198.72 | 126.23 | 75.57 | 48.79 | 81.69 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.51 | 12.41 | 3.75 | 12.56 | 12.84 | 9.57 |
Forward PE | 14.24 | 12.20 | 11.76 | 13.40 | 9.55 | 13.95 |
PS Ratio | 1.05 | 0.82 | 0.58 | 0.37 | 0.28 | 0.45 |
PB Ratio | 4.22 | 1.95 | 1.40 | 1.39 | 1.15 | 2.06 |
P/FCF Ratio | 6.98 | 6.90 | 10.76 | 4.73 | 16.43 | 9.62 |
P/OCF Ratio | 5.48 | 4.93 | 5.86 | 3.23 | 4.87 | 5.58 |
PEG Ratio | 1.69 | 0.80 | 1.66 | 2.91 | 4.77 | 1.60 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.53 | 1.52 | 1.21 | 1.23 | 1.17 | 1.21 |
EV/EBITDA Ratio | 6.60 | 6.98 | 6.20 | 6.91 | 6.77 | 6.89 |
EV/EBIT Ratio | 7.98 | 8.58 | 7.78 | 9.05 | 9.05 | 9.19 |
EV/FCF Ratio | 10.16 | 12.79 | 22.42 | 15.64 | 70.09 | 25.88 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.38 | 1.61 | 1.68 | 2.94 | 3.54 | 3.94 |
Debt / EBITDA Ratio | 2.39 | 2.86 | 3.22 | 3.96 | 4.37 | 4.38 |
Debt / FCF Ratio | 3.98 | 5.70 | 12.84 | 9.99 | 50.88 | 18.43 |
Net Debt / Equity Ratio | 1.10 | 1.28 | 1.32 | 2.71 | 3.35 | 3.38 |
Net Debt / EBITDA Ratio | 2.06 | 2.48 | 2.79 | 4.06 | 4.64 | 4.22 |
Net Debt / FCF Ratio | 3.18 | 4.54 | 10.09 | 9.20 | 48.11 | 15.83 |
Asset Turnover | 0.73 | 0.73 | 0.72 | 0.74 | 0.70 | 0.71 |
Inventory Turnover | 37.16 | 36.00 | 32.91 | 31.23 | 30.74 | 32.49 |
Quick Ratio | 1.28 | 1.51 | 1.54 | 1.09 | 1.09 | 1.22 |
Current Ratio | 1.59 | 1.76 | 1.78 | 1.51 | 1.34 | 1.39 |
Return on Equity (ROE) | 41.70% | 27.02% | 57.83% | 25.92% | 22.58% | 41.34% |
Return on Assets (ROA) | 8.68% | 8.04% | 7.03% | 6.32% | 5.67% | 5.86% |
Return on Invested Capital (ROIC) | 17.09% | 15.80% | 12.35% | 11.21% | 9.55% | 11.13% |
Return on Capital Employed (ROCE) | 16.10% | 15.00% | 13.10% | 11.90% | 11.00% | 11.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 11.75% | 8.06% | 26.66% | 7.96% | 7.79% | 10.44% |
FCF Yield | 14.32% | 14.49% | 9.30% | 21.15% | 6.08% | 10.40% |
Buyback Yield / Dilution | 8.43% | 7.20% | 6.60% | 5.17% | -1.79% | -2.17% |